In SURMOUNT-5, gastrointestinal adverse events were the most common with both medications and were generally mild to moderate
With its multifaceted benefits, tirzepatide is a powerful tool in the pursuit of successful weight loss and improved health
Following the publication of the guidelines, criticism and questions have emerged
Leerink Partners analyst David Risinger said he expects volume growth of the companies' obesity drug prescriptions to start picking up in July, with "rapid adoption" over the second half of the year
Methods In this open-label, single-center, casecontrol pilot study, patients with IIH (pwIIH) and a body mass index (BMI) of 30 kg/m 2 were offered to receive a GLP-1-RA (semaglutide, liraglutide) in addition to the usual care weight management (UCWM)
So instead he landed up working on the proglucagon gene